^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Ocular Melanoma

Related cancers:
3d
Don't Miss the Blind Spots: Incidental Detection of Choroidal Melanoma During Primary Care Evaluation of Visual Field Loss. (PubMed, Cureus)
Vision improved following four sessions of proton beam therapy. This case highlights the importance of multidisciplinary involvement, multimodal imaging, and gene expression profiling in facilitating early diagnosis and treatment.
Journal
|
GNAQ (G Protein Subunit Alpha Q) • SF3B1 (Splicing Factor 3b Subunit 1) • PRAME (Preferentially Expressed Antigen In Melanoma)
|
SF3B1 mutation
3d
New Paradigm in Ocular Surface Squamous Neoplasia-Insights from a Case Report on the Use of Interferon in Treatment. (PubMed, Oncol Res)
This case underscores the clinical effectiveness and favorable tolerability of topical interferon alpha-2b in the management of recurrent ocular surface squamous neoplasia. The achievement of durable remission after a shortened treatment course highlights its potential as a flexible therapeutic option, with meaningful implications for clinical practice, particularly in settings with limited access to biologic therapies.
Journal
|
IFNA1 (Interferon Alpha 1)
10d
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma (clinicaltrials.gov)
P2, N=12, Active, not recruiting, H. Lee Moffitt Cancer Center and Research Institute | N=37 --> 12 | Trial primary completion date: Dec 2026 --> Jul 2026 | Recruiting --> Active, not recruiting
Enrollment closed • Enrollment change • Trial primary completion date
|
Keytruda (pembrolizumab) • Lynparza (olaparib)
14d
A Macrophage/Monocyte-Related Four-Gene Signature for Prognostic Assessment of Uveal Melanoma: BTBD6, C2CD4B, CCL24, and S100A4. (PubMed, Hum Mutat)
A significant negative correlation between RiskScore and the IC50 of XMD8-85, lapatinib, roscovitine, salubrinal, bexarotene, LFM-A13, FTI-277, and TGX221 chemotherapeutic agents was further noticed. In this study, we computationally identified genes associated with both disease progression and macrophage/monocyte-related characteristics in UVM and constructed a prognostic risk model with predicted immune infiltration patterns. These findings generate testable hypotheses that may inform future experimental studies on the immune mechanisms underlying UVM.
Journal • Gene Signature
|
CD8 (cluster of differentiation 8) • S100A4 (S100 calcium binding protein A4)
|
lapatinib • Targretin oral (bexarotene oral) • TGX-221 • salubrinal • seliciclib (CYC202)
15d
Amentoflavone Suppresses Stemness of Retinoblastoma Cell via Targeting Smoothened (SMO) Protein. (PubMed, Stem Cells Int)
These analyses revealed that AMF directly targets smoothened (SMO) to disrupt the SHh signaling pathway, thereby suppressing RB stem cell (RBSC) self-renewal and tumor progression. This work uncovers a previously unreported mechanism by which AMF hinders RB development and highlights its potential as a promising therapeutic candidate for this aggressive pediatric cancer.
Journal
|
CD44 (CD44 Molecule) • POU5F1 (POU Class 5 Homeobox 1) • NANOG (Nanog Homeobox)
|
POU5F1 expression
17d
Choroidal melanoma edge recurrence 13 years after I125 plaque brachytherapy. (PubMed, Am J Ophthalmol Case Rep)
This case illustrates a rare late local recurrence of choroidal melanoma with different appearance from the original tumor. It also highlights the diagnostic and prognostic role of transretinal biopsy in confirming the nature of the lesion as a recurrence and the option of proton beam radiation as salvage therapy.
Journal
|
BAP1 (BRCA1 Associated Protein 1) • GNA11 (G Protein Subunit Alpha 11) • SOX10 (SRY-Box 10)
17d
Right-lobe hepatic mucinous cystic neoplasm with an adjacent large hemorrhagic-appearing cyst: Markedly elevated serum CEA and CA19-9 despite benign imaging/pathology. (PubMed, Radiol Case Rep)
Serum levels of CEA and CA19-9 normalized one month postoperatively, and no recurrence has been observed during follow-up. When a multilocular cystic mass with cyst-in-cyst morphology and a stained glass-like appearance is identified in the liver-even in the absence of definite malignant imaging features-MCN should be considered, including in cases arising in the right hepatic lobe.
Journal
|
CA 19-9 (Cancer antigen 19-9)
20d
Molecular etiology and therapeutic advances in retinoblastoma. (PubMed, Cancer Genet)
Understanding the underlying mechanisms involved in RB and exploring new treatment strategies is a crucial step toward developing more effective and less invasive therapeutic approaches that can improve patient outcomes. This review summarizes the significant genetic and epigenetic alterations involved in RB tumorigenesis, current therapeutic strategies, and future treatment prospects for patients with RB.
Review • Journal
|
RB1 (RB Transcriptional Corepressor 1) • MYCN (MYCN Proto-Oncogene BHLH Transcription Factor)
|
MYCN amplification
20d
HYGROMEL: Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas (clinicaltrials.gov)
P=N/A, N=32, Terminated, Centre Antoine Lacassagne | Phase classification: P2 --> P=N/A
Phase classification
21d
GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma. (PubMed, Cancer Res)
Analogous PAX3 positive populations were also identified in mouse and human single-cell transcriptomic datasets. Collectively, these findings establish a critical role for Mitfa-independent melanocyte progenitors in UM pathogenesis.
Journal
|
GNAQ (G Protein Subunit Alpha Q) • FN1 (Fibronectin 1) • PAX3 (Paired Box 3)
|
BRAF V600E
28d
Types of phacomatosis pigmentovascularis associated with nevus cesius. (PubMed, Acta Dermatovenerol Alp Pannonica Adriat)
A high frequency of NA and the Klippel-Trénaunay phenotype (or leg-length discrepancy) was observed in phacomatosis melanocesioflammea. The existence of "pseudodidymosis cesioanemica" is also corroborated.
Review • Journal
|
GNAQ (G Protein Subunit Alpha Q) • GNA11 (G Protein Subunit Alpha 11)